New shot aims to stop rare, painful swelling attacks
Disease control
Recruiting now
This study is testing whether regular injections of an experimental drug called navenibart can safely prevent the sudden, painful swelling attacks caused by hereditary angioedema (HAE). About 145 adults and teens with HAE will receive either the drug or a placebo (dummy shot) for…
Phase: PHASE3 • Sponsor: Astria Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC